Sphenopalatine ganglion block for the treatment of postdural puncture headache

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300069233

Enrollment

Unknown

Registered

2023-03-10

Start date

2023-03-10

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postdural puncture headache

Interventions

Treatment group:Sphenopalatine ganglion block

Control group:Use saline injection in the same way

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Patients with pain after elective epidural puncture; 2. Aged range from 18 to 45 years; 3. American Society of Anesthesiologists (ASA) Grades I to II; 4. BMI 20 ~ 30 kg/m^2; 5. Consent of the patient's family members was obtained before surgery, and informed consent was signed.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to drugs such as ropivacaine or lidocaine; 2. Patients who have undergone turbinate surgery or nasal cavity tumor; 3. Complicated with important organ diseases and serious mental disorders.

Design outcomes

Primary

Measure	Time frame
Orthostatic pain;	—

Secondary

Measure	Time frame
Comprehensive satisfaction of postoperative analgesia;	—

Countries

China

Contacts

Public ContactYang Aiping

Second Hospital of Lanzhou University

305849760@qq.com+86 181 5206 8788

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026